Oracle Alpha’s AdaptHealth AHCO Stock Holding History

Oracle Alpha’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$348K	Buy	30,210 +2,288	+8%	+$19.4K	0.62%	51
2023 Q4	$204K	Buy	+27,922	New	+$220K	0.26%	188

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Oracle Alpha's AHCO Position: Q1 2024 in Review

Oracle Alpha increased its AdaptHealth (AHCO) stake by 8.2% in Q1 2024, buying an estimated $19.4K and bringing the position to 30,210 shares worth $348K. The position accounts for 0.62% of the portfolio, ranked #51.

Oracle Alpha first reported a position in AHCO in Q4 2023 and has held it in 2 quarters since. 210 funds tracked by Wall St. Rank hold AHCO as of Q1 2024.

Oracle Alpha held 30,210 shares of AdaptHealth worth $348K as of Q1 2024.
Oracle Alpha bought 2,288 AdaptHealth shares in Q1 2024, an estimated $19.4K.
AdaptHealth made up 0.62% of Oracle Alpha's portfolio in Q1 2024, its #51 holding.
Oracle Alpha first reported a position in AdaptHealth in Q4 2023 and has held it in 2 quarters since.
210 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.